Meqsel 0.5mg
Meqsel 0.5mg is a combination with dabrafenib is indicated for the treatment of adult patients with advanced non-small cell lung cancer with a BRAF V600 mutation.
Side Effects:-
- Mouth sores
- Acne-like rash
- Facial swelling
- Dry or itching skin
- Changed urine output
- Increased blood pressure